Expression of proto-oncogene Wip1 in breast cancer and its clinical significance

National Medical Journal of China

Volumn 90, Issue 8, 2010, Pages 519-522

  Yang, De Hua ^a   He, Jia An ^a   Li, Jian ^a   Ma, Wen Feng ^a   Hu, Xin Hua ^a   Xin, Shi Jie ^a   Duan, Zhi Quan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasms; P53; Proto oncogene; Wip1

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; PROTEIN; PROTEIN P53; PROTOONCOGENE PROTEIN WIP1; UNCLASSIFIED DRUG; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2C;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRECANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; WESTERN BLOTTING; ADULT; AGED; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; PHOSPHOPROTEIN PHOSPHATASES;

EID: 84871453822     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.08.005     Document Type: Article

References (7)

1. Bulavin D V, Demidov O N, Saito S, et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet, 2002, 31: 210-215.
2. Li J, Yang Y, Peng Y, et al. Oncogenic properties of PPM ID located within a breast cancer amplification epicenter at 17q23. Nat Genet, 2002, 31: 133-134.
3. Belova G I, Demidov O N, Fornace A J, et al. Chemical inhibition of Wip1 phosphatase contributes to suppression of tumorigenesis. Cancer Biol Ther, 2005, 4: 1154-1158.
4. Yu E, Ahn Y S, Jang S J, et al. Overexpression of the Wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers. Breast Cancer Res Treat, 2007, 101: 269-278.
5. Lu X, Nguyen T A, Moon S H, et al. The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metastasis Rev, 2008, 27: 123-135.
6. 2005, 22: 633-655.
7. 2005, 85: 3-6.